$MGNX 3 SEC Filings

Filed On	Filing
13 Jan 2025	Form 3: Smith Beth Ann, VP, Controller & Treasurer Holds 7,889 shares of Common Stock
05 Jan 2023	Form 3: Chhabra Meenu, Director No securities owned
05 Jan 2023	Form 3: Liu Margaret, Director No securities owned
24 May 2022	Form 3: Heiden William K, Director No securities owned
11 Jun 2021	Form 3: Biotech Target N V, 10% owner and 1 other Holds 6,025,564 shares of Common Stock
12 Feb 2021	Form 3: O'Brien Federica F., Director No securities owned
06 Jul 2020	Form 3: Eck Stephen L., Chief Medical Officer No securities owned
03 Jul 2018	Form 3: Macrogenics Inc, 10% owner · Provention Bio, Inc.
15 Nov 2017	Form 3: Siegel Jay Philip, Director No securities owned
22 May 2017	Form 3: Peters Jeffrey Stuart, Acting General Counsel
25 Jan 2017	Form 3: Ferrante Karen Jean, Director No securities owned
25 Jan 2017	Form 3: Jackson Scott Thomas, Director No securities owned
27 May 2016	Form 3: Spitznagel Thomas, Vice President, Development
09 Jun 2014	Form 3: Saran Atul, See Remarks Holds 22,500 shares of Common Stock
07 Mar 2014	Form 3: Fust Matthew K, Director Holds 500 shares of Common Stock
09 Oct 2013	Form 3: Tpg Group Holdings (SBS) Advisors, Inc., 10% owner and 2 others
09 Oct 2013	Form 3: Alta Biopharma Partners Iii Lp, 10% owner and 2 others
09 Oct 2013	Form 3: Interwest Partners Viii Lp, 10% owner and 8 others
09 Oct 2013	Form 3: Risser Eric Blasius, V P, Business Development Holds 13,316 shares of Common Stock
09 Oct 2013	Form 3: Stewart Stanford John, V P, Clinical Oncology

Comments